Abstract：
In 2022, endoscopic enucleation of the prostate (EEP) is the treatment of choice for benign prostatic obstruction (BPO) for glands >80 ml and is a valid alternative for patients with bleeding disorders. Unlike robot-assisted radical prostatectomy, EEP has no additional access-related trauma and can be performed using the same instruments as for bipolar enucleoresection. With favorable costs, EEP can serve as a global solution for BPO treatment.
摘要：
2022年，内窥镜前列腺摘除术（EEP）是>80ml腺体良性前列腺梗阻（BPO）的首选治疗方法，是出血性疾病患者的有效替代方法。与机器人辅助前列腺癌根治术不同,EEP没有其他与通路相关的创伤，可以使用与双极核苷酸切除术相同的仪器进行。以有利的成本，EEP可以作为BPO治疗的全球解决方案。
